Dimensional Fund Advisors LP Nektar Therapeutics Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 504,224 shares of NKTR stock, worth $468,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares

504,224

Previous 515,998 2.28%

Holding current value

$468,928

Previous $639,000 2.5%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$1.11 - $1.48 $13,069 - $17,425	-11,774 Reduced 2.28%	504,224 $655,000
Q2 2024 Aug 09, 2024	SELL	$0.9 - $1.83 $24,987 - $50,808	-27,764 Reduced 5.11%	515,998 $639,000
Q1 2024 May 10, 2024	SELL	$0.49 - $0.96 $1,422 - $2,786	-2,903 Reduced 0.53%	543,762 $505,000
Q4 2023 Feb 07, 2024	SELL	$0.42 - $0.57 $17,356 - $23,554	-41,324 Reduced 7.03%	546,665 $306,000
Q3 2023 Nov 09, 2023	SELL	$0.51 - $1.05 $112,740 - $232,113	-221,060 Reduced 27.32%	587,989 $352,000
Q2 2023 Aug 09, 2023	SELL	$0.53 - $1.03 $675,968 - $1.31 Million	-1,275,412 Reduced 61.19%	809,049 $469,000
Q1 2023 May 12, 2023	SELL	$0.64 - $3.15 $297,976 - $1.47 Million	-465,588 Reduced 18.26%	2,084,461 $1.46 Million
Q4 2022 Feb 09, 2023	BUY	$2.03 - $4.28 $2.63 Million - $5.55 Million	1,297,677 Added 103.62%	2,550,049 $5.76 Million
Q3 2022 Nov 10, 2022	SELL	$3.04 - $5.14 $1.33 Million - $2.24 Million	-436,597 Reduced 25.85%	1,252,372 $4.01 Million
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $994,213 - $1.94 Million	-313,632 Reduced 15.66%	1,688,969 $6.42 Million
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $1.88 Million - $6.19 Million	451,433 Added 29.1%	2,002,601 $10.8 Million
Q4 2021 Feb 09, 2022	BUY	$10.83 - $18.41 $3.1 Million - $5.27 Million	286,155 Added 22.62%	1,551,168 $21 Million
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $4.5 Million - $6.49 Million	-344,619 Reduced 21.41%	1,265,013 $22.7 Million
Q2 2021 Aug 12, 2021	BUY	$16.52 - $20.4 $10.9 Million - $13.4 Million	657,701 Added 69.09%	1,609,632 $27.6 Million
Q1 2021 May 14, 2021	BUY	$16.56 - $25.46 $2.78 Million - $4.28 Million	167,962 Added 21.42%	951,931 $19 Million
Q4 2020 Feb 25, 2021	BUY	$15.77 - $19.03 $12.4 Million - $14.9 Million	783,969 New	783,969 $13.3 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Nektar Therapeutics Transaction History